JB Chemicals & Pharmaceuticals Limited informed the market that Ms. Sushree Mishra has ceased to be General Manager – Corporate Strategy, Communication and In-licensing, with effect from the close of business hours on March 13, 2026. The accompanying resignation letter indicates her last working day would be March 15, 2026, subject to organizational requirements.
Ms. Mishra’s portfolio spanned corporate strategy, communications and in-licensing — a cross-functional remit that sits at the heart of growth, partnerships and how the company presents itself to markets and partners. Her departure arrives at a juncture when JB Chemicals & Pharmaceuticals continues to pursue its strategic agenda and external collaborations in a competitive pharmaceutical landscape.
JB Chemicals & Pharmaceuticals thanked Mishra for her contributions and said it would ensure a smooth transition of responsibilities during the notice period. The release did not specify a successor or a timeline for filling the role, underlining the company’s focus on leadership continuity in the corporate strategy function.
As the company charts the next phase of its strategic plans, industry observers will be watching how JB Chemicals & Pharmaceuticals reorganizes this critical executive branch and who steps in to steer strategy, communications and in-licensing in the months ahead.